TLRY Tilray

New Year, New Chill: Explore the Latest Cannabis Beverages from Solei, Mollo, and XMG

New Year, New Chill: Explore the Latest Cannabis Beverages from Solei, Mollo, and XMG

TORONTO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- . (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer goods company, offers a wide range of innovative and refreshing cannabis beverages for every taste, perfect for any occasion. Consumers are invited to explore the Solei, Mollo, and XMG cannabis brands in Canada for a variety of cannabinoid offerings and flavours, catering to different lifestyles.

Tilray Brands is leading the way in the cannabis beverage market in Canada, offering an extensive portfolio of brands and products to meet the diverse preferences of consumers. From refreshing fruit-based beverages to classic cream sodas with delicious flavours, Tilray Brands ensures there is something for everyone in their versatile brands and THC beverages.

Seltzers

Mollo Seltzers offers a range of refreshing and delicious seltzer flavours that are perfect for those looking to expand their current go-to list:

  • Blackberry: Meant for sipping back and unwinding, Mollo’s Blackberry Seltzer is loaded with sweet and tart ripe berry flavours, with 10mg of nano-emulsified THC and 20mg of CBG per 355mL can.
  • *NEW* Wildberry Acai: Coming Soon!
  • *NEW* Watermelon Lime: Coming Soon!



Sparkling Beverages and Teas

Solei sparkling beverages are a great way to experiment with mocktail options whether you’re unwinding after a long day, adding a little something special to go along with a mid-day pick-me-up, or serving up some infused options for your next social gathering.

  • Blood Orange: Invigorating citrus in a can with mild sweetness and tart, floral flavours, with 5mg THC, 10mg CBG.
  • Dark Cherry: Complex dark cherry flavours with just the right amount of sweetness featuring 5mg THC, 10mg CBD.
  • Dragonfruit Watermelon: A perfectly blended and mildly sweet dragonfruit and juicy watermelon fusion with a low dose of 1.1mg THC, 25mg CBD.
  • Mango Passionfruit: A sweet, tropical blend of mango and passionfruit, mixed in perfect harmony featuring a low dose of 1.1mg THC, 25mg CBD.

For those looking for a carbonation-free option, Solei’s Cold Brew Teas are made using a black tea base blended with real fruit juice in 355mL cans and come in two unique and invigorating flavours at 5mg THC and 10mg CBG:

  • Peach Cranberry: Refreshing peach and cranberry blended with cold brew tea
  • Wildberry Hibiscus: Juicy wild berries and hibiscus blended with cold-brew tea



Sodas

XMG’s sodas offer a series of bubbly beverages with nostalgic flavours that deliver peak refreshment, with cannabinoid variations that provide the ultimate chill:

XMG+:

  • Blackberry Lemonade: Very berry refreshment mingles with bold tartness in XMG+ Blackberry Lemonade. You’ll be sipping on sunshine with real lemon and blackberry fruit juices infused with nano-emulsified 10mg THC, 10mg CBG and <30mg caffeine from guarana extract.
  • Iced Rocket Berry: Ignite your tastebuds with an ice-cold blast of berry and lime featuring 10mg THC and 10mg CBG, including guarana extract in a 355mL can.

XMG Zero (10mg THC each):

  • Cream Soda Zero: Enjoy every sip with this dreamy blend of vanilla and caramel flavours with 10mg THC and 0 calories
  • Cherry Cola Zero: Cherry Cola Zero comes with all-natural flavours and a rollercoaster of classic cherry cola vibes with 10mg THC and 0 calories
  • Orange Soda Zero: Bold, citrus satisfaction in a can, this one’s sure to take you back to the good old days with a side of 10mg THC and 0 calories.



Mollo Seltzers, Solei CBD and CBG Beverages, and XMG Sodas are perfect for anyone seeking innovative, non-traditional alternatives to celebrating life’s moments. These products are available nationwide across Canada at select local retail stores and online. For more information on Solei, Mollo and XMG brands, visit Tilray.com.

About Tilray Brands

Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy, wellness and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on how we are elevating lives through moments of connection, visit  and follow @Tilray on all social platforms.

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, and the Company’s ability to commercialize new and innovative products worldwide. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.

For Further Information Please Contact:

Media: 

Investors: 

Photos accompanying this announcement are available at:



EN
30/12/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tilray

 PRESS RELEASE

Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Ye...

Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Year U.S. Brewing and Commercial Partnership NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), a leading global consumer packaged goods company and the fourth-largest craft beer brewer in the United States, today announced that it has entered into an exclusive licensing agreement starting January 1, 2027 with the Carlsberg Group, one of the world’s premier brewing organizations and among the largest globally by revenue. Under the terms of the agreement, Tilray has been granted a m...

 PRESS RELEASE

Tilray erweitert den pharmazeutischen Zugang im Vereinigten Königreich...

Tilray erweitert den pharmazeutischen Zugang im Vereinigten Königreich durch eine strategische Vereinbarung mit Smartway Pharmaceuticals CC-Pharma-Vereinbarung fördert das Wachstum von Tilray im Vereinigten Königreich und stärkt den Vertrieb über Apotheken- und Krankenhauskanäle NEW YORK und LONDON, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, die Pharmasparte von Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), gab heute bekannt, dass ihr europäisches pharmazeutisches Vertriebsunternehmen CC Pharma eine strategische Vereinbarung mit , einem führenden pharmazeutischen Vertriebspartner...

 PRESS RELEASE

Tilray élargit son accès aux produits pharmaceutiques au Royaume-Uni g...

Tilray élargit son accès aux produits pharmaceutiques au Royaume-Uni grâce à un accord stratégique avec Smartway Pharmaceuticals L’accord avec CC Pharma renforce la croissance de Tilray au Royaume-Uni, consolidant sa distribution auprès des pharmacies et des hôpitaux NEW YORK et LONDRES, 13 févr. 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, la division pharmaceutique de Tilray Brands, Inc. (Nasdaq : TLRY ; TSX : TLRY), a annoncé aujourd'hui que son activité de distribution pharmaceutique européenne, CC Pharma, a conclu un accord stratégique avec , un partenaire de distribution pharmaceutique...

 PRESS RELEASE

Tilray Expands UK Pharmaceutical Access Through Strategic Agreement wi...

Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals CC Pharma Agreement Bolsters Tilray’s UK Growth, Strengthening Distribution to Pharmacy and Hospital Channels NEW YORK and LONDON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that its European pharmaceutical distribution business, CC Pharma, has entered into a strategic agreement with , a leading UK-based pharmaceutical distribution partner, to expand the availability of pharmaceutical products...

 PRESS RELEASE

CC Pharma von Tilray als eines der 100 innovativsten Unternehmen in De...

CC Pharma von Tilray als eines der 100 innovativsten Unternehmen in Deutschland ausgezeichnet Die Auszeichnung würdigt CC Pharma als innovativen Marktführer und vertrauenswürdigen Partner auf dem europäischen Pharmamarkt DENSBORN, Deutschland, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, die Pharmasparte von Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), gab heute bekannt, dass , ihr europäischer Pharmahändler, zu einem der ernannt wurde. Hierbei handelt es sich um eine der renommiertesten und unabhängigsten Auszeichnungen für Innovation bei kleinen und mittleren Unternehmen des La...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch